Skip to main
MLTX
MLTX logo

MoonLake Immunotherapeutics (MLTX) Market Capitalization Overview

Market Cap: $2.81B as of Jun 13, 2025

$2.81B
Past Month+$415.76M (17.39%)
As of Jun 13, 2025, MoonLake Immunotherapeutics (MLTX) has a market capitalization of $2.81B. Over the past 30 days, its market cap has decreased by -0.68%, while in the last 12 months, it has decreased by -17.83%.

Market capitalization represents the total value of MoonLake Immunotherapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

MoonLake Immunotherapeutics (MLTX) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of MoonLake Immunotherapeutics (MLTX) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

MoonLake Immunotherapeutics (MLTX) Market Cap History

DateMarket CapChange
Jun 2, 2025$2.62B-0.68%
May 1, 2025$2.64B+14.35%
Apr 1, 2025$2.31B-8.46%
Mar 3, 2025$2.52B-8.71%
Feb 3, 2025$2.76B-18.52%
Jan 2, 2025$3.38B-3.43%

MoonLake Immunotherapeutics (MLTX) End of Year Market Cap History

DateMarket CapChange
2025$2.81B-17.83%
2024$3.42B-5.66%
2023$3.62B+784.47%
2022$409.27M+179.51%
2021$146.43M-13.02%
2020$168.34M

FAQs About MoonLake Immunotherapeutics (MLTX) Market Cap

As of Jun 13, 2025, the market capitalization of MoonLake Immunotherapeutics (MLTX) is $2.81B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, MoonLake Immunotherapeutics’s market capitalization has increased by 17.39%, changing from $2.40B to $2.81B as of Jun 13, 2025.

In the last 3 months, MoonLake Immunotherapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, MoonLake Immunotherapeutics’s market capitalization decreased from $3.62B in January to $3.42B in December, reflecting a -5.66% change.

In the past five years, MoonLake Immunotherapeutics (MLTX) has had a compound annual growth rate (CAGR) of 82.58% in market capitalization. This means its market cap has grown at an average rate of 82.58% per year.

MoonLake Immunotherapeutics (MLTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.